Recent Spin Mural Oncology At An Attractive Discount To Cash And Portfolio Value (NASDAQ:MURA)
wildpixel The main draw here is that recent spin-off Mural Oncology (NASDAQ:MURA) reported $275M in cash in their January 2024 investor presentation (as of Nov 1, 2023). That works out to approximately $16.47/share in cash, compared to a current stock price of $5.39/share. Now, the catch is that this is a biotech company investing in…